<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1727-897X</journal-id>
<journal-title><![CDATA[MediSur]]></journal-title>
<abbrev-journal-title><![CDATA[Medisur]]></abbrev-journal-title>
<issn>1727-897X</issn>
<publisher>
<publisher-name><![CDATA[Universidad de Ciencias Médicas de Cienfuegos, Centro Provincial de Ciencias Médicas, Provincia de Cienfuegos.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1727-897X2022000300568</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Parálisis periódica tirotóxica hipopotasémica. Presentación de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Hypokalemic thyrotoxic periodic paralysis. A case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas Delgado]]></surname>
<given-names><![CDATA[Carlos David]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rojas Delgado]]></surname>
<given-names><![CDATA[Ana Ginella]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Eugenio Espejo  ]]></institution>
<addr-line><![CDATA[Quito ]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Loja  ]]></institution>
<addr-line><![CDATA[Loja ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2022</year>
</pub-date>
<volume>20</volume>
<numero>3</numero>
<fpage>568</fpage>
<lpage>571</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1727-897X2022000300568&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1727-897X2022000300568&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1727-897X2022000300568&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN La parálisis periódica tirotóxica hipopotasémica es una entidad poco frecuente, con mayor prevalencia en el género masculino, y en la población asiática; caracterizada por debilidad muscular, asociada a hipopotasemia, y como una complicación del hipertiroidismo, generalmente secundario a enfermedad de Graves. El tratamiento se basa en la reposición del déficit de potasio, vigilancia cardiovascular, y manejo de la enfermedad de base, con restauración del eutiroidismo. Se presenta un paciente de 38 años de edad, con varios antecedentes patológicos personales, quien acudió por asistencia médica a causa de un cuadro clínico de 48 horas de evolución de tetraparesia, sin otra sintomatología.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Hypokalemic thyrotoxic periodic paralysis is a rare entity, with a higher prevalence in males, and in the Asian population; characterized by muscle weakness, associated with hypokalaemia, and as a complication of hyperthyroidism, usually secondary to Graves' disease. Treatment is based on replacement of the potassium deficit, cardiovascular monitoring, and management of the underlying disease, with restoration of euthyroidism. A 38-years-old patient is presented, with several personal pathological antecedents, who came for medical assistance due to a 48-hour clinical picture of tetraparesis, with no other symptoms.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Parálisis periódica hipopotasémica]]></kwd>
<kwd lng="es"><![CDATA[hipertiroidismo]]></kwd>
<kwd lng="es"><![CDATA[tirotoxicosis]]></kwd>
<kwd lng="en"><![CDATA[Hypokalemic periodic paralysis]]></kwd>
<kwd lng="en"><![CDATA[hyperthyroidism]]></kwd>
<kwd lng="en"><![CDATA[thyrotoxicosis]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vijayakumar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ashwath]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Thimmappa]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thyrotoxic periodic paralysis clinical challenges]]></article-title>
<source><![CDATA[J Thyroid Res]]></source>
<year>2014</year>
<volume>2014</volume>
<page-range>649502</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wilches]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thyrotoxic periodic paralysis Diversity in America]]></article-title>
<source><![CDATA[J Emerg Med]]></source>
<year>2014</year>
<volume>46</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>760-2</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pothiwala]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analytic Review Thyrotoxic Periodic Paralysis: A Review]]></article-title>
<source><![CDATA[Intensive Care Med]]></source>
<year>2010</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>71-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[XB]]></given-names>
</name>
<name>
<surname><![CDATA[Zhao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thyrotoxic periodic paralysis in the chinese population Clinical features in 45 cases]]></article-title>
<source><![CDATA[Exp Clin Endocrinol Diabetes]]></source>
<year>2010</year>
<volume>118</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>22-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[JF.]]></given-names>
</name>
</person-group>
<source><![CDATA[Parálisis periódica hipopotasémica tirotóxica]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Ambato, Ecuador ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Técnica de Ambato]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rhee]]></surname>
<given-names><![CDATA[EP]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Dighe]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A 37-year-old man with muscle pain, weakness, and weight loss]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2012</year>
<volume>366</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>553-60</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arosemena]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Balda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parálisis Periódica Hipopotasémica Tirotóxica, Una Emergencia Neuroendocrina: Artículo de Revisión.]]></article-title>
<source><![CDATA[Rev Ecuat Neurol]]></source>
<year>2020</year>
<volume>29</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shefner]]></surname>
<given-names><![CDATA[JM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Approach to the patient with muscle weakness]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Waltham, MA ]]></publisher-loc>
<publisher-name><![CDATA[UpToDate Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mount]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[Uptodate. Clinical manifestations and treatment of hypokalemia in adults]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Waltham, MA ]]></publisher-loc>
<publisher-name><![CDATA[UpToDate Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Muñoz]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
<name>
<surname><![CDATA[Tolsa]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lara]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Parálisis periódica tirotóxica: revisión de la literatura y reporte de caso en un hospital universitario mexicano privado de alta especialidad.]]></article-title>
<source><![CDATA[Rev Mex Neurocienc]]></source>
<year>2019</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shiang]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Cheng]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Hung]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years]]></article-title>
<source><![CDATA[Eur J Endocrinol]]></source>
<year>2009</year>
<volume>161</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>911-6</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutmann]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Conwit]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Hyperkalemic periodic paralysis]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Waltham, MA ]]></publisher-loc>
<publisher-name><![CDATA[UpToDate Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[RY]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evaluating the efficacy of primary treatment for graves&amp;apos; disease complicated by thyrotoxic periodic paralysis]]></article-title>
<source><![CDATA[Int J Endocrinol]]></source>
<year>2014</year>
<volume>2014</volume>
<page-range>949068</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
